Column Group LLC

CIK: 0001833486Latest portfolio: $82.8M · Q4 2025

Holdings

Total Value

$82.8M

New Positions

Closed Positions

Top Holdings

#	Stock	Shares	Value	% Portfolio	Change
1	SRZNSurrozen, Inc.	1,851,350	$41.8M	50.54%	+352K
2	ORICORIC Pharmaceuticals Inc.	3,540,777	$29.0M	34.98%	—
3	TNYATenaya Therapeutics, Inc.	9,400,290	$6.7M	8.08%	—
4	RAPTEURRAPT Therapeutics Inc	156,270	$5.3M	6.39%	-9,805
5	RVMDRevolution Medicines Inc	46	$3K	0.00%	—

Sector Breakdown

Healthcare0.0% ($418402.9T)

Unknown0.0% ($5.3M)

Filing History

Quarter	Filing Date	Portfolio Value	Holdings
Q4 2025	Feb 13, 2026	$82.8M	5
Q3 2025	Nov 14, 2025	$81.0B	5
Q2 2025	Aug 15, 2025	$65.7B	5
Q1 2025	May 14, 2025	$44.2B	5
Q4 2024	Feb 14, 2025	$55.7B	5

Fund Information

CIK0001833486

Most Recent FilingFeb 13, 2026

Number of Filings5

View on SEC EDGAR →

Column Group LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $82.8M across 5 holdings. The largest position is Surrozen, Inc. (SRZN), representing 50.5% of the portfolio. Compared to the previous quarter, the fund opened 0 new positions and closed 0 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.